<bill session="114" type="h" number="2338" updated="2015-07-25T06:38:31-04:00">
  <state datetime="2015-05-14">REFERRED</state>
  <status>
    <introduced datetime="2015-05-14"/>
  </status>
  <introduced datetime="2015-05-14"/>
  <titles>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes.</title>
  </titles>
  <sponsor id="400320"/>
  <cosponsors/>
  <actions>
    <action datetime="2015-05-14" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2015-05-15">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="114" type="h" number="6"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Health information and medical records"/>
    <term name="Medical research"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
</bill>
